Publications by authors named "Alexey Arkhipov"

Background: Aortic atresia with ventricular septal defect is a very rare congenital cardiac anomaly, especially in combination with aortic arch interruption. It is always challenging to choose the optimal treatment tactics for such patients. One of the possible types of intervention is the Yasui procedure.

View Article and Find Full Text PDF

Anomalous origin of the left subclavian artery from the pulmonary artery is a rare congenital cardiac malformation. We describe a case of anomalous origin of the left subclavian artery from the pulmonary artery in a patient who presented with symptoms of vertebrobasilar insufficiency and underwent reimplantation of the left subclavian artery into the left common carotid artery from the supraclavicular approach.

View Article and Find Full Text PDF

Objectives: This study aimed to compare vacuum-assisted closure therapy (VAC) and closed irrigation drainage therapy (CID) for deep sternal wound infection treatment in infants.

Methods: From January 2008 to March 2018, 69 patients (1.73%) had deep sternal wound infection.

View Article and Find Full Text PDF

Aim: This study compared outcomes following the double-patch and Warden procedures for correcting partial anomalous connection of the right pulmonary veins to the superior vena cava.

Methods: Eighty (80) patients, aged <18years old, and with partial anomalous connection of the right pulmonary veins to the superior vena cava were randomly assigned into double-patch method (n=40) and Warden procedure (n=40) groups. The median follow-up was 22.

View Article and Find Full Text PDF

Objectives: Perventricular device closure (PVDC) of ventricular septal defects (VSDs) has demonstrated excellent clinical results. However, no prospective studies have compared PVDC with the conventional approach (CA).

Methods: Between June 2012 and August 2014, 640 consecutive patients with isolated VSD were enrolled in the study, and randomized into the PVDC group ( n  =   320) and the CA group ( n  =   320).

View Article and Find Full Text PDF

Currently, minimally invasive cardiac surgery has found widespread use even in congenital heart surgery. The number of defects, which can be corrected through a small incision or totally endoscopic, is on the rise. Nowadays, surgeons can repair atrial septal defect, ventricular septal defect, patent ductus arteriosus and other congenital heart defects using minimally invasive techniques.

View Article and Find Full Text PDF

We describe a new technique of perventricular closure of a perimembranous ventricular septal defect on a beating heart using transesophageal echocardiography guidance and video-assisted thoracoscopy. Ventricular septal defects were closed successfully, and no shunts, rhythm disorders, or valve incompetence developed during the short hospital stay. This procedure is safe and effective for selected patients.

View Article and Find Full Text PDF

Objective: To present our first experience in perventricular closure of ventricular septal defect, which is in our opinion, an important adjunct to current ventricular septal defect treatment options.

Background: Surgical closure under cardiopulmonary bypass is the treatment of choice for a perimembranous ventricular septal defect. Percutaneous techniques have technical limitations.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Alexey Arkhipov"

  • - Alexey Arkhipov's recent research primarily focuses on innovative surgical techniques and interventions for congenital cardiac anomalies, particularly in infants and children, addressing complex cases like interrupted aortic arch and anomalous origins of arteries.
  • - He has conducted comparative studies on treatment methods, such as vacuum-assisted closure versus closed irrigation for deep sternal wound infections, and various surgical techniques for closing ventricular septal defects, highlighting the effectiveness of minimally invasive methods.
  • - His work emphasizes the evolution of cardiac surgery approaches, showcasing improved patient outcomes and reduced invasiveness, ultimately contributing to the advancement of pediatric cardiac surgery practices.